BEAM

NASDAQStock

Beam Therapeutics Inc.

$25.40-0.69 (-2.65%)

52-Week Range

$14.54
$35.41

Key Stats

Market Cap

2.6B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.17

Volume

1.9M

Avg Volume

2.0M

Performance

1M

-1.54%

3M

-4.62%

6M

+20.25%

YTD

-5.71%

1Y

+2.11%

3Y

-25.04%

5Y

-73.01%

Price Chart

ETF Exposure

BEAM is held by 96 ETFs

ETFFund NameWeight
FHLCFIDELITY MSCI HEALTH CARE INDEX ETF0.04%
VXFVanguard Extended Market ETF0.03%
VBVanguard Small-Cap ETF0.03%
FESMFIDELITY ENHANCED SMALL CAP ETF0.03%
WSMLiShares MSCI World Small-Cap ETF0.02%
GSSCGoldman Sachs ActiveBeta U.S. Small Cap Equity ETF0.02%
SMMDiShares Russell 2500 ETF0.02%
DFACDimensional - US Core Equity 2 ETF0.01%
DCORDimensional - US Core Equity 1 ETF0.01%
SMLFiShares U.S. Small-Cap Equity Factor ETF0.01%
HDGProShares - Hedge Replication ETF0.01%
ONEQFIDELITY NASDAQ COMPOSITE INDEX ETF0.01%
OMFSInvesco Russell 2000 Dynamic Multifactor ETF0.01%
TILTFlexShares Morningstar U.S. Market Factor Tilt Index Fund0.01%
DFAUDimensional - US Core Equity Market ETF0.01%
ESGVVanguard ESG U.S. Stock ETF0.01%
DFUSDimensional - US Equity Market ETF0.00%
ITOTiShares Core S&P Total U.S. Stock Market ETF0.00%
IWViShares Russell 3000 ETF0.00%
SCHBSchwab U.S. Broad Market ETF0.00%
V3AL.LVanguard ESG Global All Cap UCITS ETF (USD) Distributing0.00%
VTHRVanguard Russell 3000 ETF0.00%
VTIVanguard Total Stock Market ETF0.00%
AVUSAvantis U.S. Equity ETF0.00%
GTPEGoldman Sachs MSCI World Private Equity Return Tracker ETF0.00%
ITDGiShares LifePath Target Date 2055 ETF0.00%
ITDHiShares LifePath Target Date 2060 ETF0.00%
ITDIiShares LifePath Target Date 2065 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.00%
SPGMState Street SPDR Portfolio MSCI Global Stock Market ETF0.00%
VTVanguard Total World Stock ETF0.00%
DFSUDimensional - US Sustainability Core 1 ETF0.00%
EAOAiShares ESG Aware 80/20 Aggressive Allocation ETF0.00%
EAOMiShares ESG Aware 40/60 Moderate Allocation ETF0.00%
EAORiShares ESG Aware 60/40 Balanced Allocation ETF0.00%
ITDDiShares LifePath Target Date 2040 ETF0.00%
ITDEiShares LifePath Target Date 2045 ETF0.00%
ITDFiShares LifePath Target Date 2050 ETF0.00%
EAOKiShares ESG Aware 30/70 Conservative Allocation ETF0.00%
ITDBiShares LifePath Target Date 2030 ETF0.00%
ITDCiShares LifePath Target Date 2035 ETF0.00%
LSLTPacer Salt Low truBeta US Market ETF0.00%
SLTPacer Salt High truBeta US Market ETF0.00%
TRPLPacer Metaurus US Large Cap Dividend Multiplier 300 ETF0.00%
VETSPacer Military Times Best Employers ETF0.00%
VIRSPacer BioThreat Strategy ETF0.00%
PreviousPage 2 of 2

About BEAM ETF Exposure

Beam Therapeutics Inc. (BEAM) is held by 96 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 2.6B, BEAM is a widely held institutional stock. The stock currently trades at $25.40. Investors can gain exposure to BEAM through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold BEAM, sorted by portfolio weight.